. Author manuscript; available in PMC: 2023 Jul 1.

Published in final edited form as: JCSM Rapid Commun. 2022 Jun 20;5(2):254–265. doi: 10.1002/rco2.68

Table 2.

Plasma ceramide ratios are able to distinguish cachectic from non-cachectic PDAC patients.

	Non-Cachectic (n=18)	Cachectic (n=35)	AUROC (95% CI)	Optimal Cutoff	p value
C18:C24	0.0933 ± 0.0387	0.2009 ± 0.0467	0.810 (0.679–0.921)	>0.055	0.0087
C18:C22	0.2236 ± 0.0495	0.3757 ± 0.0546	0.783 (0.633–0.910)	>0.203	0.0075
C20:C24	0.1042 ± 0.0404	0.1923 ± 0.0478	0.773 (0.630–0.903)	>0.062	0.0196
C18–1:C24	0.0021 ± 0.0005	0.0064 ± 0.0015	0.757 (0.615–0.8)	>0.0015	0.0048
SPA:C24	0.0028 ± 0.0003	0.0042 ± 0.0005	0.732 (0.593–0.863)	>0.0043	0.0098
C24 alone	3.097 ± 0.1577	2.474 ± 0.1627	0.730 (0.598–0.858)	<2.55	0.0074

Mean ± SEM, AUROC (95% CI of the mean), p values are from ROC analysis.